Option Care Health (OPCH) Tops Q4 EPS by 3c, provides guidance
Option Care Health (NASDAQ: OPCH) reported Q4 EPS of $0.32, $0.03 better than the analyst estimate of $0.29. Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.09 billion.
GUIDANCE:
Option Care Health sees FY2024 revenue of $4.6-4.8 billion, versus the consensus of $4.625 billion.
Adjusted EBITDA of $425 million to $450 million
Cash flow from operations of at least $300 million
Additionally, the Company anticipates an effective tax rate of 26% - 28% and net interest expense of approximately $55 million to $60 million.
For earnings history and earnings-related data on Option Care Health (OPCH) click here.
